Dataset from A Phase 1, Open-label, Fixed-sequence Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074 in Healthy Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009320
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this study is to evaluate the effect of multiple doses of the UGT
inhibitor valproic acid on the single-dose pharmacokinetics of BIIB074. The secondary
objectives of this study are to evaluate the safety and tolerability of BIIB074 when
administered alone and when coadministered with the UGT inhibitor valproic acid and to
evaluate the effect of the UGT inhibitor valproic acid on the PK of the M13, M14, and M16
metabolites of BIIB074.
创建时间：
2025-07-07
